Evidence map›Paper›PMID 25866626›Full record

ArticleInfectious diseases of poverty2015

Ebola, the killer virus.

Haider Ghazanfar, Fizza Orooj, Muhammad Ahmed Abdullah, Ali Ghazanfar

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Infectious Diseases of Poverty, the first five years.Infectious diseases of poverty · 2017
    Article
  5. Ethics of trial drug use: to give or not to give?BEOnline : journal of the West African bioethics training program · 2016
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Haider GhazanfarShifa College of Medicine, Pitras Bukhari Road H-8/4, Islamabad, Pakistan.
Fizza OroojShifa College of Medicine, Pitras Bukhari Road H-8/4, Islamabad, Pakistan.
Muhammad Ahmed AbdullahShifa College of Medicine, Pitras Bukhari Road H-8/4, Islamabad, Pakistan.
Ali GhazanfarFederal Medical and Dental College, Prime Minister's National Health Complex, Chak Shahzad, Islamabad, Pakistan.
Shifa International Hospital · PKDar Al-Shifa Hospital · PSPrime Minister's Office · BN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ebola virus disease (EVD) has mostly affected economically deprived countries as limited resources adversely affect a country's infrastructure and administration. Probing into the factors that led to the widespread outbreak, setting forth plans to counter EVD cases in developing countries, and devising definitive measures to limit the spread of the disease are essential steps that must be immediately taken. In this review we summarize the pathogenesis of EVD and the factors that led to its spread. We also highlight interventions employed by certain countries that have successfully limited the epidemic, and add a few preventive measures after studying the current data. According to the available data, barriers to prevent and control the disease in affected countries include irresolute and disorganized health systems, substandard sanitary conditions, poor personal hygiene practices, and false beliefs and stigma related to EVD. The public health sector along with the respective chief authorities in developing countries must devise strategies, keeping the available resources in mind, to deal with the outbreak before it occurs. As a first step, communities should be educated on EVD's symptoms, history, mode of transmission, and methods of protection, including the importance of personal hygiene practices, via seminars, newspapers, and other social media. A popular opinion leader (POL) giving this information would further help to remove the misconception about the nature of the disease and indirectly improve the quality of life of affected patients and their families.

Indexed as

Ebola hemorrhagic feverEbola/prevention and controlEbola/transmissionEbola virus/physiologyEpidemiologyHemorrhagic fever

Identifiers

PMID25866626
PMCPMC4393611
OpenAlexW2091570091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.